NCM · Biotechnology

Vyome Holdings, Inc. (HIND) Stock

$2.01 -3.83% NCM: HIND Healthcare

Valuation

MetricValue
Price$2.01
Market Cap$14.11M
P/E Ratio-0.07
P/B Ratio2.59
P/S Ratio120.65
EPS (TTM)$-4.75
52-Week High$6.56
52-Week Low$1.75
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-254.62%
ROA-123.23%
ROCE-100.00%
Gross Margin48.16%
Operating Margin-4.02%
Net Margin-9.85%
Debt/Equity0.00
Current Ratio1.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$14.0M$11.0M$9.0M$8.0M$0
Operating Profit$-58.0M$-27.0M$-15.0M$-8.0M$-3.0M
Net Profit$-63.0M$-46.0M$-11.0M$-7.0M$-10.0M
EPS$-419004.00$-157897.00$-2771.94$-345.74$-4.75
Op Margin-425.6%-240.9%-168.7%-96.5%-859.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$53.0M$11.0M$11.0M$5.0M$6.0M
Total Liabilities$8.0M$8.0M$4.0M$5.0M$3.0M
Cash$23.0M$4.0M$5.0M$1.0M$5.0M
Borrowings$0$0$0$1.0M$0

Latest News

Vyome Granted Chinese Patent Strengthening Immuno-Inflammation Portfolio Business Wire · Jul 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-15.0M$-22.0M$-17.0M$-4.0M$-4.0M
Investing Cash Flow$2.0M$0$0$0$0
Financing Cash Flow$0$2.0M$0$0$0
Net Cash Flow$20.0M$-19.0M$1.0M$-4.0M$5.0M
Free Cash Flow$-16.0M$-22.0M$-17.0M$-4.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.67
FCF Yield-29.84%
Quick Ratio1.67
Interest Coverage-101.07
Return 1Y-80.30%
Return 3Y-99.97%
Return 5Y-100.00%

Ownership

Insiders Held52.88%
Institutions Held1.52%
Institutions Float Held3.23%
Institutional HolderSharesReport Date
Geode Capital Management, LLC25,7932026-03-31
UBS Group AG22,6752026-03-31
Focus Partners Wealth14,6402026-03-31
Vanguard Fiduciary Trust Co12,1952026-03-31
Vanguard Capital Management LLC9,4632026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARMPArmata Pharmaceuticals, Inc. $3.63 +0.00% -0.72 $133.26M 0.00%
CCCCC4 Therapeutics, Inc. $3.06 -3.16% -2.95 $338.34M 0.00%
CDXSCodexis, Inc. $1.41 +0.00% -4.05 $151.66M 0.00%
CGENCompugen Ltd. $2.07 -2.82% 6.15 $195.73M 0.00%
IMDXInsight Molecular Diagnostics Inc. $3.17 -5.93% -2.12 $102.36M 0.00%

About Vyome Holdings, Inc.

Vyome Holdings, Inc. is led by CEO Venkateswarlu Nelabhotla, employs 18 people, headquartered in US, publicly traded since 2016.

Vyome Holdings, Inc. (HIND) stock trades at $2.01 with a market capitalization of $14.11M. The stock is valued at a price-to-earnings (P/E) ratio of -0.07, price-to-book of 2.59, price-to-sales of 120.65. Over the past 52 weeks the stock has ranged between $1.75 and $6.56, and currently trades 69.4% below its 52-week high.

On profitability, Vyome Holdings, Inc. generates a return on equity (ROE) of -254.62%, return on capital employed of -100.00%, an operating margin of -4.02%, a net profit margin of -9.85%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1182.62 +0.28% JNJ Johnson & Johnson $263.73 +0.88% ABBV AbbVie Inc. $281.04 +1.65% MRK Merck & Company, Inc. Common Stock (new) $145.45 -0.10% UNH UnitedHealth Group Incorporated Common Stock (DE) $378.52 -0.21% NVS Novartis AG $143.84 +0.06% AZN AstraZeneca PLC $158.33 -0.55% TMO Thermo Fisher Scientific Inc $662.24 +0.64% AMGN Amgen Inc. $417.57 +0.65% GILD Gilead Sciences, Inc. $150.43 -0.49% ABT Abbott Laboratories $101.82 +2.23% NVO Novo Nordisk A/S $38.58 -0.16%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides